The Pivotal Role of Phosphoinositide-3 Kinase in the Human Somatostatin sst4 Receptor-Mediated Stimulation of p44/p42 Mitogen-Activated Protein Kinase and Extracellular Acidification

1999 ◽  
Vol 263 (1) ◽  
pp. 239-243 ◽  
Author(s):  
Keiran S.M. Smalley ◽  
Wasyl Feniuk ◽  
Lynda A. Sellers ◽  
Patrick P.A. Humphrey
Keyword(s):  
Protein Kinase ◽  
Mitogen Activated Protein Kinase ◽  
Pivotal Role ◽  
Extracellular Acidification ◽  
Mitogen Activated Protein ◽  
Phosphoinositide 3 Kinase ◽  
Stimulation Of

Permissive effect of EGFR-activated pathways on RVI and their anti-apoptotic effect in hypertonicity-exposed mIMCD3 cells

2011 ◽  
Vol 31 (6) ◽  
pp. 489-497 ◽  
Author(s):  
Alejandro Ruiz-Martínez ◽  
Erika Vázquez-Juárez ◽  
Gerardo Ramos-Mandujano ◽  
Herminia Pasantes-Morales
Keyword(s):  
Cell Death ◽  
Protein Kinase ◽  
Apoptotic Cell ◽  
Growth Factor Receptor ◽  
Mitogen Activated Protein Kinase ◽  
Egfr Inhibition ◽  
Mitogen Activated Protein ◽  
Apoptotic Effect ◽  
Phosphoinositide 3 Kinase

Hypertonicity is a stressful stimulus leading to cell shrinkage and apoptotic cell death. Apoptosis can be prevented if cells are able to activate the mechanism of RVI (regulatory volume increase). This study in mIMCD3 cells presents evidence of a permissive role of the EGFR (epidermal growth factor receptor) on RVI, achieved for the most part through the two main EGFR-triggered signalling chains, the MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) and the PI3K (phosphoinositide 3-kinase)/Akt (also known as protein kinase B) pathways. Hyperosmotic solutions (450 mosM) made by addition of NaCl, increased EGFR phosphorylation, which is prevented by GM6001 and AG1478, blockers respectively, of MMPs (matrix metalloproteinases) and EGFR. Inhibition of EGFR, ERK (PD98059) or PI3K/Akt (wortmannin) phosphorylation reduced RVI by 60, 48 and 58% respectively. The NHE (Na+/H+ exchanger) seems to be the essential mediator of this effect since (i) NHE is the main contributor to RVI, (ii) EGFR, ERK and PI3K/Akt blockers added together with the NHE blocker zoniporide reduce RVI by non-additive effects and (iii) All the blockers significantly lowered the NHE rate in cells challenged by an NH4Cl pulse. Besides reducing RVI, the inhibition of MMP, EGFR and PI3K/Akt had a strong pro-apoptotic effect increasing cell death by 2–3.7-fold. This effect was significantly lower when RVI inhibition did not involve the EGFR-PI3K/Akt pathway. These results provide evidence that Akt and its permissive effect on RVI have a predominant influence on cell survival under hypertonic conditions in IMCD3 cells. This role of Akt operates under the influence of EGFR activation, promoted by MMP.

scholarly journals Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the α4β1 integrin to mitogen-activated protein kinase signalling

2000 ◽  
Vol 345 (2) ◽  
pp. 385-392 ◽  
Author(s):  
Lisa D. FINKELSTEIN ◽  
Yoji SHIMIZU
Keyword(s):  
Protein Kinase ◽  
Adaptor Protein ◽  
Dominant Negative ◽  
Mitogen Activated Protein Kinase ◽  
Hl60 Cells ◽  
Intracellular Signals ◽  
Extracellular Signal ◽  
Mitogen Activated Protein ◽  
Phosphoinositide 3 Kinase ◽  
Stimulation Of

Cell adhesion mediated by β1 integrin receptors leads to the initiation of intracellular signals that affect cell differentiation and survival. Here we have analysed the mechanism by which the α4β1 integrin activates the mitogen-activated protein kinase pathway in HL60 cells, a myelomonocytic cell line that lacks the expression of focal adhesion kinase. A role for phosphoinositide 3-kinase (PI-3K) in α4 integrin-mediated activation of extracellular signal-regulated protein kinase 2 (ERK2) is suggested by the ability of PI-3K inhibitors and a dominant-negative form of the p85 subunit of PI-3K to block the activation of ERK2 by integrin. Stimulation of α4β1 integrins on HL60 cells also leads to increased tyrosine phosphorylation of the 120 kDa adaptor protein Cbl. PI-3K activity associated with Cbl also increases on the stimulation of α4β1 integrins, although immunodepletion experiments suggest that Cbl-associated PI-3K does not account for all of the PI-3K activity induced on the stimulation of integrins in these cells. The expression of wild-type Cbl or the 70Z/3 Cbl mutant enhances basal ERK2 activity in transfectants with a minimal effect on α4 integrin-mediated ERK2 activity. In contrast, overexpression of the Hut Cbl truncation mutant, which does not associate with p85, has no effect on the ERK2 pathway. These results suggest that PI-3K has a major role in coupling α4β1 integrins to ERK2 activation in myeloid cells and that the Cbl adaptor protein has a role in basal, but not α4β1 integrin-mediated, activation of ERK2.

Sign in / Sign up

Export Citation Format

Share Document